147 related articles for article (PubMed ID: 688724)
1. The interaction between indomethacin and probenecid. A clinical and pharmacokinetic study.
Baber N; Halliday L; Sibeon R; Littler T; Orme ML
Clin Pharmacol Ther; 1978 Sep; 24(3):298-307. PubMed ID: 688724
[TBL] [Abstract][Full Text] [Related]
2. Clinical Pharmacokinetics of indomethacin.
Helleberg L
Clin Pharmacokinet; 1981; 6(4):245-58. PubMed ID: 7249487
[TBL] [Abstract][Full Text] [Related]
3. Probenecid-clofibrate interaction.
Veenendaal JR; Brooks PM; Meffin PJ
Clin Pharmacol Ther; 1981 Mar; 29(3):351-8. PubMed ID: 7471606
[TBL] [Abstract][Full Text] [Related]
4. Probenecid: its chromatographic determination, plasma protein binding, and in vivo pharmacokinetics in dogs.
Kakizaki T; Yokoyama Y; Natsuhori M; Karasawa A; Kubo S; Yamada N; Ito N
J Vet Med Sci; 2006 Apr; 68(4):361-5. PubMed ID: 16679727
[TBL] [Abstract][Full Text] [Related]
5. Determination of indomethacin, its metabolites and their glucuronides in human plasma and urine by means of direct gradient high-performance liquid chromatographic analysis. Preliminary pharmacokinetics and effect of probenecid.
Vree TB; van den Biggelaar-Martea M; Verwey-van Wissen CP
J Chromatogr; 1993 Jul; 616(2):271-82. PubMed ID: 8376508
[TBL] [Abstract][Full Text] [Related]
6. Probenecid inhibits the glucuronidation of indomethacin and O-desmethylindomethacin in humans. A pilot experiment.
Vree TB; van den Biggelaar-Martea M; Verwey-van Wissen CP; van Ewijk-Beneken Kolmer EW
Pharm World Sci; 1994 Feb; 16(1):22-6. PubMed ID: 8156046
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent kinetics of probenecid in rhesus monkeys-intravenous bolus studies.
Chiang CW; Benet LZ
Pharmacology; 1981; 23(6):326-36. PubMed ID: 7312942
[TBL] [Abstract][Full Text] [Related]
8. The effects of probenecid upon the individual components of indomethacin elimination.
Duggan DE; Hooke KF; White SD; Noll RM; Stevenson CR
J Pharmacol Exp Ther; 1977 May; 201(2):463-70. PubMed ID: 404419
[TBL] [Abstract][Full Text] [Related]
9. Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man.
Homeida M; Roberts C; Branch RA
Clin Pharmacol Ther; 1977 Oct; 22(4):402-9. PubMed ID: 902453
[TBL] [Abstract][Full Text] [Related]
10. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.
Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W
Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947
[TBL] [Abstract][Full Text] [Related]
11. The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination.
Ings RM; Reeves DS; White LO; Bax RP; Bywater MJ; Holt HA
J Pharmacokinet Biopharm; 1985 Apr; 13(2):121-42. PubMed ID: 4057054
[TBL] [Abstract][Full Text] [Related]
12. Non-linear elimination and protein binding of probenecid.
Emanuelsson BM; Beermann B; Paalzow LK
Eur J Clin Pharmacol; 1987; 32(4):395-401. PubMed ID: 3609117
[TBL] [Abstract][Full Text] [Related]
13. Effects of sodium salicylate on elimination kinetics of indomethacin and bile production in dogs.
Beck WS; Dietzel K; Geisslinger G; Engler H; Vergin H; Brune K
Drug Metab Dispos; 1990; 18(6):962-7. PubMed ID: 1981545
[TBL] [Abstract][Full Text] [Related]
14. A renal mechanism for the clofibric acid-probenecid interaction.
Meffin PJ; Zilm DM; Veenendaal JR
J Pharmacol Exp Ther; 1983 Dec; 227(3):739-42. PubMed ID: 6655567
[TBL] [Abstract][Full Text] [Related]
15. Physiologically based pharmacokinetic model for the renal clearance of iodopyracet and the interaction with probenecid in the dog.
Russel FG; Wouterse AC; Van Ginneken CA
Biopharm Drug Dispos; 1989; 10(2):137-52. PubMed ID: 2706315
[TBL] [Abstract][Full Text] [Related]
16. Probenecid impairment of acetaminophen and lorazepam clearance: direct inhibition of ether glucuronide formation.
Abernethy DR; Greenblatt DJ; Ameer B; Shader RI
J Pharmacol Exp Ther; 1985 Aug; 234(2):345-9. PubMed ID: 4020675
[TBL] [Abstract][Full Text] [Related]
17. Probenecid inhibits the metabolic and renal clearances of zidovudine (AZT) in human volunteers.
Hedaya MA; Elmquist WF; Sawchuk RJ
Pharm Res; 1990 Apr; 7(4):411-7. PubMed ID: 2362917
[TBL] [Abstract][Full Text] [Related]
18. No effect of probenecid on the renal and biliary clearances of digoxin in man.
Hedman A; Angelin B; Arvidsson A; Dahlqvist R
Br J Clin Pharmacol; 1991 Jul; 32(1):63-7. PubMed ID: 1888643
[TBL] [Abstract][Full Text] [Related]
19. Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid.
Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Jaehde U; Reiter A; Naber KG; Rodamer M; Sörgel F
Br J Clin Pharmacol; 2010 Feb; 69(2):167-78. PubMed ID: 20233180
[TBL] [Abstract][Full Text] [Related]
20. Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex.
de Miranda P; Good SS; Yarchoan R; Thomas RV; Blum MR; Myers CE; Broder S
Clin Pharmacol Ther; 1989 Nov; 46(5):494-500. PubMed ID: 2582706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
